Literature DB >> 10841228

The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not.

D Hall.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10841228     DOI： 10.1016/s0735-1097(00)00637-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Mode of death in heart failure: findings from the ATLAS trial.

Authors:  P A Poole-Wilson; B F Uretsky; K Thygesen; J G F Cleland; B M Massie; L Rydén
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 2.  Anticoagulation and heart failure.

Authors:  S P Graham
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

Review 3.  Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice.

Authors:  Jakub Gawrys; Karolina Gawrys; Ewa Szahidewicz-Krupska; Arkadiusz Derkacz; Jakub Mochol; Adrian Doroszko
Journal:  Biomed Res Int       Date:  2018-10-02       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.